|
CN102946872A
|
|
Micropellet compositions comprising pancreatin containing digestive enzyme mixtures
|
|
TW201143758A
|
|
Syringe filter cap and method of using the same for administration of medication dosage
|
|
IE20100799A1
|
|
Pharmaceutical composites of poorly water soluble drugs and polymers
|
|
BRPI0807718A2
|
|
STABLE DIGESTIVE ENZYME COMPOSITIONS, METHOD OF DOSAGE, PACKAGING, USE AND PREPARATION PROCESS OF SUCH COMPOSITIONS
|
|
IE20070900A1
|
|
New anticancer conjugates
|
|
IE20070508A1
|
|
Medicaments with effect on brain metastases
|
|
NZ573756A
|
|
1,2-dithiolan-3-pentanoic acid or thioctic acid pellets
|
|
IE20060565A1
|
|
Drug delivery system based on regioselectively amidated hyaluronic acid
|
|
EP1888069A2
|
|
Antiproliferative drug
|
|
IE20060049A1
|
|
A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents
|
|
WO2006047493A2
|
|
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
|
US2006105038A1
|
|
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
WO2005049306A1
|
|
Ultrasound-assisted compaction process with a compaction device made of coupled plastic-metal materials
|
|
US2005025824A1
|
|
Pulsatile release histamine H2 antagonist dosage form
|
|
GB0312468D0
|
|
Composition
|
|
WO03074028A1
|
|
Process for loading and thermodynamically activating drugs on polymers by means of supercritical fluids
|
|
EP1534251A1
|
|
Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
|
|
US7951399B2
|
|
Process for activation of drugs in a vibrational mill
|
|
WO03000739A1
|
|
Regioselectively reticulated polysaccharides
|
|
AU2002312970B2
|
|
New derivatives of hyaluronan
|
